Business News

Professional Services News

Novoheart Grants Options

VANCOUVER, BRITISH COLUMBIA–(Marketwired – March 23, 2018) - Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSX VENTURE:NVH)(FRANKFURT:3NH) announced [...]

Avid Bioservices Receives Six 2018 CMO Leadership Awards

TUSTIN, Calif., March 22, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]

Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery

HOUSTON, TX–(Marketwired – March 20, 2018) – Moleculin Biotech, Inc. (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical [...]

Tetra Bio-Pharma Added to Leading Cannabis ETF: Horizons Marijuana Life Sciences Index

OTTAWA, ONTARIO–(Marketwired – March 20, 2018) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in [...]

Oncolytics Biotech(R) Scientist Selected to Participate in the Society of Immunotherapy of Cancer’s (SITC) METIOR Incubator Program

CALGARY, AB and SAN DIEGO, CA–(Marketwired – March 20, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN® (pelareorep), [...]

NeoGenomics Announces Executive Appointments

FT. MYERS, FL–(Marketwired – March 20, 2018) – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the appointment of [...]

VistaGen Therapeutics Receives a Notice of Allowance for Another Key U.S. Patent Covering Oral Formulations of AV-101

SOUTH SAN FRANCISCO, CA–(Marketwired – March 19, 2018) – VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation [...]

Tetra Bio-Pharma Completes Acquisition of Remaining 20% Interest in PhytoPain Pharma Inc.

OTTAWA, ONTARIO–(Marketwired – March 19, 2018) - Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation“) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced the [...]

Avalon GloboCare Submits Listing Application for The NASDAQ Capital Market

FREEHOLD, NJ–(Marketwired – March 19, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today it has filed an [...]

Knight annonce une entente de licence exclusive avec Ardelyx pour la licence de Tenapanor

MONTRÉAL, QUÉBEC–(Marketwired – 19 mars 2018) - Thérapeutique Knight inc. (TSX:GUD) (« Knight »), a annoncé aujourd’hui une [...]

page  1  of  39